NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,343,627 | +103.3% | 461,827 | +108.7% | 0.01% | +125.0% |
| Q2 2023 | $1,644,356 | +197.8% | 221,313 | +177.8% | 0.00% | +300.0% |
| Q1 2023 | $552,134 | +176.2% | 79,673 | +309.7% | 0.00% | 0.0% |
| Q4 2022 | $199,936 | +156.3% | 19,449 | +355.9% | 0.00% | – |
| Q3 2022 | $78,000 | -73.5% | 4,266 | -25.3% | 0.00% | -100.0% |
| Q2 2022 | $294,000 | -87.7% | 5,712 | -82.4% | 0.00% | -80.0% |
| Q1 2022 | $2,385,000 | +279.8% | 32,389 | +835.8% | 0.01% | +400.0% |
| Q1 2021 | $628,000 | -75.4% | 3,461 | -85.3% | 0.00% | -83.3% |
| Q3 2020 | $2,548,000 | -60.0% | 23,519 | -69.2% | 0.01% | -62.5% |
| Q2 2020 | $6,366,000 | +1545.0% | 76,379 | +167.8% | 0.02% | +1500.0% |
| Q1 2020 | $387,000 | +74.3% | 28,520 | -48.9% | 0.00% | – |
| Q4 2019 | $222,000 | +181.0% | 55,836 | +253.8% | 0.00% | – |
| Q3 2019 | $79,000 | -7.1% | 15,784 | +8.6% | 0.00% | – |
| Q2 2019 | $85,000 | – | 14,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |